Send feedback

SGCA p.Arg221Pro

c.662G>C · rs138254713 · VCV497670

Likely pathogenic Expert panel
Classification
Likely pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.6996 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 6.2e-05%)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PM2_Supporting PP4_Strong PP3 PM3

Curation rationale (ClinGen, verbatim)

The NM_000023.4: c.662G>C variant in SGCA is a missense variant predicted to cause substitution of arginine by proline at amino acid 221 (p.Arg221Pro). This variant has been detected in at least one individual with autosomal recessive limb girdle muscular dystrophy who was compound heterozygous for the variant and a pathogenic variant (c.585-1G>A, 1.0 pt, Washington University internal clinic data communication) (PM3). At least one patient with this variant displayed progressive limb girdle muscle weakness and absent expression of alpha-sarcoglycan protein, which is highly specific for SGCA-related LGMD (PP4_Strong, Washington University internal clinic data communication). This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_Supporting). The computational predictor REVEL gives a score of 0.765, which is above the threshold of ≥0.70, evidence that correlates with impact to SGCA function (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): PM2_Supporting, PP3, PM3, PP4_Strong.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.6996likely pathogenic ✓ concordant with ClinVar
REVEL0.765pathogenic-leaning
SaProtLLR -12.22damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI<0.2all four deltas below 0.2 · G>T here scores Δ0.35 · evaluated, not missing
Constraint at this position
ConservationphyloP 9.9GERP 1.5, phastCons 1
Regional constrainto/e 0.91unconstrained · MANE · 9,393 bp · p 0.033 · regional, not allelic
Overall
CADD27.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 6.2e-05%
Overall 6.2e-05% 1/1,613,916 alleles · very rare exomes 1/1,461,770 · genomes 0/152,146 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SGCA
Protein
p.Arg221Pro
Coding
c.662G>C
MANE Select
NM_000023
dbSNP
rs138254713
Type
single nucleotide variant
Location
chr17:50169169 (GRCh38)
Gene constraint
LOEUF 1.273 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 80.15
Full SGCA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sgca-p-arg221pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown